-+ 0.00%
-+ 0.00%
-+ 0.00%

Sanofi’s Efdoralprin Alfa Shows Superiority in Phase 2 Study for Alpha-1 Antitrypsin Deficiency Emphysema

路透·12/23/2025 14:53:05

登录查看新闻详情